Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial

1. Bellmunt, J.
2. Hussain, M.
3. Gschwend, J.E.
4. Albers, P.
5. Oudard, S.
6. Castellano, D.
7. Daneshmand, S.
8. Nishiyama, H.
9. Majchrowicz, M.
10. Degaonkar, V.
11. Shi, Y.
12. Mariathasan, S.
13. Grivas, P.
14. Drakaki, A.
15. O'Donnell, P.H.
16. Rosenberg, J.E.
17. Geynisman, D.M.
18. Petrylak, D.P.
19. Hoffman-Censits, J.
20. Bedke, J.
21. Kalebasty, A.R.
22. Zakharia, Y.
23. van der Heijden, M.S.
24. Sternberg, C.N.
25. Davarpanah, N.N.
26. Powles, T.
27. Alle Autoren anzeigen +